DE602004028513D1 - Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern - Google Patents
Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markernInfo
- Publication number
- DE602004028513D1 DE602004028513D1 DE602004028513T DE602004028513T DE602004028513D1 DE 602004028513 D1 DE602004028513 D1 DE 602004028513D1 DE 602004028513 T DE602004028513 T DE 602004028513T DE 602004028513 T DE602004028513 T DE 602004028513T DE 602004028513 D1 DE602004028513 D1 DE 602004028513D1
- Authority
- DE
- Germany
- Prior art keywords
- endometrial
- markers
- phase
- procedure
- markers associated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57442—Specifically defined cancers of the uterus and endometrial
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/367—Infertility, e.g. sperm disorder, ovulatory dysfunction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/36—Gynecology or obstetrics
- G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53260103P | 2003-12-23 | 2003-12-23 | |
US63099004P | 2004-11-24 | 2004-11-24 | |
PCT/CA2004/002172 WO2005061725A1 (en) | 2003-12-23 | 2004-12-21 | Methods for detecting markers associated with endometrial disease or phase |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004028513D1 true DE602004028513D1 (de) | 2010-09-16 |
Family
ID=34713798
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004028513T Active DE602004028513D1 (de) | 2003-12-23 | 2004-12-21 | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern |
Country Status (7)
Country | Link |
---|---|
US (1) | US20080226554A1 (de) |
EP (2) | EP1711618B1 (de) |
AT (1) | ATE476525T1 (de) |
AU (1) | AU2004303448A1 (de) |
CA (1) | CA2550900A1 (de) |
DE (1) | DE602004028513D1 (de) |
WO (1) | WO2005061725A1 (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050100967A1 (en) * | 2003-07-11 | 2005-05-12 | Science & Technology Corporation @ Unm | Detection of endometrial pathology |
DE102005059242A1 (de) | 2005-12-12 | 2007-06-14 | Johannes Gutenberg-Universität Mainz, Vertreten Durch Den Präsidenten | Molekulare Marker für eine Tumordiagnose und -therapie |
CA2703795A1 (en) * | 2006-10-27 | 2008-05-02 | Mount Sinai Hospital | Endometrial phase or endometrial cancer biomarkers |
WO2009052504A1 (en) * | 2007-10-18 | 2009-04-23 | University Of Medicine & Dentistry Of New Jersey | Systems for and methods of detecting mastitis |
DE102007062847A1 (de) * | 2007-12-21 | 2009-12-31 | Protagen Ag | Markersequenzen für neurodegenerative Erkrankungen und deren Verwendung |
CA2618163A1 (en) * | 2008-02-07 | 2009-08-07 | K. W. Michael Siu | Head and neck cancer biomarkers |
US9684001B2 (en) | 2008-02-07 | 2017-06-20 | Ranju Ralhan | Biomarkers for head-and-neck cancers and precancers |
US20110028344A1 (en) * | 2008-04-11 | 2011-02-03 | Expression Pathology, Inc. | Biomarkers for endometrial disease |
WO2010010201A1 (es) | 2008-07-22 | 2010-01-28 | Equipo Ivi Investigacion Sl | Perfil de expresion genetica como marcador de la receptividad endometrial |
WO2012019300A1 (en) * | 2010-08-10 | 2012-02-16 | Siu K W Michael | Endometrial cancer biomarkers and methods of identifying and using same |
TWI484183B (zh) * | 2011-09-01 | 2015-05-11 | Univ Nat Cheng Kung | 癌症轉移之評估方法及生物標記、及抑制癌症轉移之siRNA化合物 |
US20150044703A1 (en) * | 2012-03-22 | 2015-02-12 | University Of South Alabama | Methods and compositions for detecting endometrial or ovarian cancer |
EP2755030A1 (de) * | 2013-01-15 | 2014-07-16 | Bergen Teknologioverforing AS | Prognosemarker für Endometriumkarzinome |
WO2015105190A1 (ja) * | 2014-01-10 | 2015-07-16 | 学校法人順天堂 | 子宮体がんのリンパ節転移能の評価方法 |
JP6713723B2 (ja) * | 2014-02-18 | 2020-06-24 | 小野薬品工業株式会社 | 過敏性腸症候群の診断用バイオマーカー |
EP4012023B1 (de) | 2014-06-17 | 2024-05-15 | Asherman Therapy, S.L. | Stammzellentherapie bei endometriumpathologien |
US11047860B2 (en) * | 2015-11-05 | 2021-06-29 | Vanderbilt University | Protein quantitation in multicellular tissue specimens |
US10140708B2 (en) * | 2016-01-21 | 2018-11-27 | Riverside Research Institute | Method for gestational age estimation and embryonic mutant detection |
EP3442706A4 (de) | 2016-04-13 | 2020-02-19 | NextGen Jane, Inc. | Probensammel- und konservierungsvorrichtungen, systeme und verfahren |
US11204355B2 (en) | 2017-02-20 | 2021-12-21 | Vanderbilt University | Immune checkpoint molecular fitness profiling by mass spectrometry |
KR101805430B1 (ko) * | 2017-04-26 | 2017-12-06 | (주)넥스젠바이오텍 | 항산화 활성 및 피부 세포 증식 효과가 증가한 열 충격 단백질의 융합단백질 및 이를 유효성분으로 함유하는 피부 주름 개선용 화장료 조성물 |
EP3655778B1 (de) * | 2017-07-21 | 2023-06-07 | Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca | Agrin als marker für endometriumkarzinom |
CN112578123B (zh) * | 2019-09-27 | 2022-10-25 | 成都中医药大学 | 检测粪钙卫蛋白含量的试剂在制备子宫病变筛查试剂盒中的用途 |
CN112190692B (zh) * | 2020-09-30 | 2023-03-31 | 复旦大学附属妇产科医院 | NrCAM在制备药物中的用途 |
CN113493839A (zh) * | 2021-09-06 | 2021-10-12 | 北京泱深生物信息技术有限公司 | 基因标志物组合在诊断子宫内膜癌中的应用 |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3867517A (en) | 1971-12-21 | 1975-02-18 | Abbott Lab | Direct radioimmunoassay for antigens and their antibodies |
US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
DE2901218A1 (de) | 1979-01-13 | 1980-07-17 | Byk Gulden Lomberg Chem Fab | Ung von theophyllin |
USRE32417E (en) | 1979-10-29 | 1987-05-12 | Summa Medical Corporation | Radiolabeled antibody to anti-tumor associated antigen and process |
US4311688A (en) | 1979-10-29 | 1982-01-19 | Serono Laboratories Inc. | Composition and method for cancer detection in humans |
US4472371A (en) | 1979-10-29 | 1984-09-18 | Summa Medical Corporation | Radiolabeled antibody to anti-tumor associated antigen and process |
US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4478818A (en) | 1982-12-27 | 1984-10-23 | Alza Corporation | Ocular preparation housing steroid in two different therapeutic forms |
US4558279A (en) | 1983-03-07 | 1985-12-10 | University Of Cincinnati | Methods for detecting and imaging a temperature of an object by nuclear magnetic resonance |
US4732864A (en) | 1983-10-06 | 1988-03-22 | E. I. Du Pont De Nemours And Company | Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
US4897255A (en) | 1985-01-14 | 1990-01-30 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
FI874419A (fi) | 1987-10-08 | 1989-04-09 | Instrumentarium Oy | Anordning och foerfarande foer undersoekning av ett objekts egenskaper. |
CA1337394C (en) * | 1987-11-17 | 1995-10-24 | Nelson N. H. Teng | Vaginal sample test and reagents |
US5109397A (en) | 1988-04-22 | 1992-04-28 | Analogic Corporation | X-ray tomography apparatus with lateral movement compensation |
US4985678A (en) | 1988-10-14 | 1991-01-15 | Picker International, Inc. | Horizontal field iron core magnetic resonance scanner |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US5437994A (en) | 1989-06-15 | 1995-08-01 | Regents Of The University Of Michigan | Method for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells |
US5399493A (en) | 1989-06-15 | 1995-03-21 | The Regents Of The University Of Michigan | Methods and compositions for the optimization of human hematopoietic progenitor cell cultures |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5103098A (en) | 1989-11-09 | 1992-04-07 | Board Of Regents, The University Of Texas System | High resolution gamma ray detectors for positron emission tomography (pet) and single photon emission computed tomography (spect) |
US5214382A (en) | 1990-02-23 | 1993-05-25 | Baylor Research Institute | Magnetic resonance imaging with selective contrast enhancement |
JPH0449949A (ja) | 1990-06-15 | 1992-02-19 | Hitachi Ltd | 磁気共鳴サーモグラフィー方法 |
US5031624A (en) | 1990-08-17 | 1991-07-16 | Wisconsin Alumni Research Foundation | Phase contrast, line-scanned method for NMR angiography |
US5317091A (en) | 1991-02-27 | 1994-05-31 | Akzo N.V. | Technetium-99m labeling of proteins |
US5210421A (en) | 1991-06-10 | 1993-05-11 | Picker International, Inc. | Simultaneous transmission and emission converging tomography |
US5474796A (en) | 1991-09-04 | 1995-12-12 | Protogene Laboratories, Inc. | Method and apparatus for conducting an array of chemical reactions on a support surface |
US5605662A (en) | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
US5208581A (en) | 1991-11-22 | 1993-05-04 | General Electric Company | High speed communication apparatus for computerized axial tomography (cat) scanners with matching receiver |
JP3160351B2 (ja) | 1992-03-13 | 2001-04-25 | 株式会社東芝 | 磁気共鳴診断装置 |
US5312922A (en) | 1992-04-06 | 1994-05-17 | Nordion International Inc. | Europium and terbium chelators for time-resolved fluorometric assays |
DE69326202T2 (de) | 1992-06-29 | 2000-04-13 | Koninkl Philips Electronics Nv | Verfahren und Gerät zur Kernresonanzabbildung |
US5272343A (en) | 1992-07-27 | 1993-12-21 | General Electric Company | Sorter for coincidence timing calibration in a PET scanner |
DE69329873T2 (de) | 1992-10-26 | 2001-09-13 | Koninkl Philips Electronics Nv | Kompensierung von Wirbelströmen in der Bilderzeugung mittels magnetischer Resonanz |
FI105293B (fi) | 1993-06-08 | 2000-07-14 | Picker Nordstar Oy | Magneettikuvaukseen käytettävän magneetin napakenkä |
JPH06347555A (ja) | 1993-06-10 | 1994-12-22 | Hamamatsu Photonics Kk | ポジトロンイメージング装置 |
US5446799A (en) | 1993-11-01 | 1995-08-29 | Picker International, Inc. | CT Scanner with improved processing efficiency 180 degrees+ fan angle reconstruction system |
US5406479A (en) | 1993-12-20 | 1995-04-11 | Imatron, Inc. | Method for rebinning and for correcting cone beam error in a fan beam computed tomographic scanner system |
US5578832A (en) | 1994-09-02 | 1996-11-26 | Affymetrix, Inc. | Method and apparatus for imaging a sample on a device |
US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
US6015880A (en) | 1994-03-16 | 2000-01-18 | California Institute Of Technology | Method and substrate for performing multiple sequential reactions on a matrix |
US5807522A (en) | 1994-06-17 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for fabricating microarrays of biological samples |
US5650135A (en) | 1994-07-01 | 1997-07-22 | The Board Of Trustees Of The Leland Stanford Junior University | Non-invasive localization of a light-emitting conjugate in a mammal |
US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
US5600145A (en) | 1995-01-19 | 1997-02-04 | Picker International, Inc. | Emission/transmission device for use with a dual head nuclear medicine gamma camera with the transmission source located behind the emission collimator |
DE19506561C1 (de) | 1995-02-24 | 1996-10-10 | Deutsches Krebsforsch | Verfahren zur Früherkennung von HPV-assoziierten Karzinomen bzw. von hochgradigen, durch HPV-verursachten Dysplasien |
US5608221A (en) | 1995-06-09 | 1997-03-04 | Adac Laboratories | Multi-head nuclear medicine camera for dual SPECT and PET imaging with monuniform attenuation correction |
US5602891A (en) | 1995-11-13 | 1997-02-11 | Beth Israel | Imaging apparatus and method with compensation for object motion |
SE9602594D0 (sv) | 1996-07-01 | 1996-07-01 | Stefan Nilsson | Förfarande och anordning vid datortomografi |
JP3384944B2 (ja) | 1996-07-11 | 2003-03-10 | ジーイー横河メディカルシステム株式会社 | Mri装置 |
WO1998010291A1 (en) * | 1996-09-06 | 1998-03-12 | Osteometer Biotech A/S | Biochemical markers of the human endometrium |
GB2319844A (en) | 1996-11-28 | 1998-06-03 | Marconi Gec Ltd | Prepolarising MRI magnet with powdered iron poles |
US5841140A (en) | 1997-01-08 | 1998-11-24 | Smv America, Inc. | Gamma camera for pet and spect studies |
JP3679892B2 (ja) | 1997-04-10 | 2005-08-03 | 株式会社東芝 | 磁気共鳴イメージング装置 |
EP0998217B1 (de) | 1997-05-23 | 2009-01-07 | ProRhythm, Inc. | Wegwerfbarer fokussierender ultraschallapplikator hoher intensität |
US5900636A (en) | 1997-05-30 | 1999-05-04 | Adac Laboratories | Dual-mode gamma camera system utilizing single-photon transmission scanning for attenuation correction of PET data |
US5946371A (en) | 1997-12-08 | 1999-08-31 | Analogic Corporation | Method and apparatus for volumetric computed tomography scanning with offset symmetric or asymmetric detector system |
US6119032A (en) | 1997-12-31 | 2000-09-12 | U.S. Philips Corporation | Method and system for positioning an invasive device by magnetic resonance (MR) imaging of an MR visible device |
WO1999045147A1 (en) * | 1998-03-05 | 1999-09-10 | Diadexus Llc | A novel method of detecting and monitoring endometrial and uterine cancers |
WO1999063116A2 (en) * | 1998-06-04 | 1999-12-09 | Reprogen, Inc. | Use of prothymosin in the diagnosis and treatment of endometriosis |
US6387629B1 (en) * | 1998-06-04 | 2002-05-14 | Reprogen, Inc. | Use of cathepsin S in the diagnosis and treatment of endometriosis |
US6121775A (en) | 1998-06-16 | 2000-09-19 | Beth Israel Deaconess Medical Center, Inc. | MRI imaging method and apparatus |
JP2002526055A (ja) * | 1998-09-23 | 2002-08-20 | ダイアデクスアス・インコーポレーテッド | 婦人科癌及び精巣癌を診断、監視、病期分類、イメージング及び治療する方法 |
US6115446A (en) | 1999-04-09 | 2000-09-05 | Arch Development Corp. | Fast reconstruction of fan-beam CT and SPECT |
US7013221B1 (en) | 1999-07-16 | 2006-03-14 | Rosetta Inpharmatics Llc | Iterative probe design and detailed expression profiling with flexible in-situ synthesis arrays |
US6777182B2 (en) * | 2000-02-25 | 2004-08-17 | Metriogene Biosciences Inc. | Methods for determining the likelihood of endometriosis in a female subject |
US6884578B2 (en) * | 2000-03-31 | 2005-04-26 | Affymetrix, Inc. | Genes differentially expressed in secretory versus proliferative endometrium |
US6649359B2 (en) * | 2000-06-01 | 2003-11-18 | The Brigham & Women's Hospital, Inc. | Diagnosis of endometrial precancers |
CA2703795A1 (en) * | 2006-10-27 | 2008-05-02 | Mount Sinai Hospital | Endometrial phase or endometrial cancer biomarkers |
-
2004
- 2004-12-21 WO PCT/CA2004/002172 patent/WO2005061725A1/en active Application Filing
- 2004-12-21 AT AT04802347T patent/ATE476525T1/de not_active IP Right Cessation
- 2004-12-21 EP EP04802347A patent/EP1711618B1/de not_active Not-in-force
- 2004-12-21 US US10/584,207 patent/US20080226554A1/en not_active Abandoned
- 2004-12-21 DE DE602004028513T patent/DE602004028513D1/de active Active
- 2004-12-21 EP EP10169645.8A patent/EP2251695B1/de not_active Not-in-force
- 2004-12-21 CA CA002550900A patent/CA2550900A1/en not_active Abandoned
- 2004-12-21 AU AU2004303448A patent/AU2004303448A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2251695A2 (de) | 2010-11-17 |
EP1711618B1 (de) | 2010-08-04 |
EP1711618A4 (de) | 2008-05-07 |
WO2005061725A1 (en) | 2005-07-07 |
CA2550900A1 (en) | 2005-07-07 |
EP1711618A1 (de) | 2006-10-18 |
US20080226554A1 (en) | 2008-09-18 |
ATE476525T1 (de) | 2010-08-15 |
AU2004303448A1 (en) | 2005-07-07 |
EP2251695A3 (de) | 2011-06-22 |
EP2251695B1 (de) | 2013-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602004028513D1 (de) | Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern | |
CY1110923T1 (el) | Συζυγη που περιλαμβανουν ενα αντισωμα ειδικο για την ed-β περιοχη της ινονεκτινης και η χρηση τους για τον εντοπισμο και την αντιμετωπιση ογκων | |
DE602004019812D1 (de) | Marker für neuromyelitis optica | |
DK1945622T3 (da) | Isotopisk-mærkede benzofuranforbindelser som billeddannelsesmidler til amyloidogene proteiner | |
WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
BR0111125A (pt) | Moléculas de ácido nucléico de nrg-2, polipeptìdeos, e métodos diagnóstico e terapêuticos | |
HK1088947A1 (en) | Use of nicotinamide n-methyltransferase as a marker for colorectal cancer | |
DE60223561D1 (de) | Verfahren zum nachweis von oxidativem stress sowie kit zur durchführung davon | |
WO2003033731A3 (en) | Methods for detecting ovarian cancer | |
DE60326748D1 (de) | Verfahren zur identifizierung des brustkrebsrisikos | |
ATE418072T1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
HUP0301812A2 (hu) | Átvizsgálási (screening) eljárás | |
WO2007020522A3 (en) | Protein markers for diagnosing of colorectal cancer and use of said markers as drug targets for the treatment of said cancer type | |
WO2004043232A3 (en) | Methods for identifying risk of melanoma and treatments thereof | |
DE60328055D1 (de) | Verfahren zum nachweis von pathogenen mykobakterien in klinischen proben | |
ATE449323T1 (de) | Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren | |
ATE417939T1 (de) | Rna-biotest | |
ATE534902T1 (de) | Replikationsproteinn ciz1 | |
DE602005023329D1 (de) | VERFAHREN ZUR DIAGNOSE NICHT-KLEINZELLIGER LUNGENKARZINOME ÜBER DIE tRNA-DIHYDROURIDIN-SYNTHASEAKTIVITÄT VON URLC8 | |
DE50204790D1 (de) | System und verfahren zum bestimmen der gangauswahl mittels wählhebel | |
DE60014064D1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
DE602004011865D1 (de) | Vorrichtung und Verfahren zur Bestimmung des Körpertyps | |
WO2004113574A3 (en) | Methods for disease screening | |
DE60329861D1 (de) | Neue, auf der antigen-antikörper-reaktion beruhende sondenplatte sowie reagenzienkit und verfahren mit verwendung der sondenplatte | |
WO2005115394A3 (en) | Prenyl-electrostatic switch, and methods of use |